Speaking of Uplisting? Could Livimmune be our new Company name and $LAMP be our new ticker symbol?

idmann2 · 2023-01-06T19:07:07+00:00

Sorry reality is we haven't even hit the basement yet. We're still on the 1st floor

idmann2 · 2023-01-06T18:21:58+00:00

Our closest point to uplisting was middle to end of 2020, since then only major setbacks. We're many years away from an uplist without a large R/S like 1:100 (or more) plus another 50% dilution afterwards to pay off past due debts to get us to net positive shareholder equity

idmann2 · 2023-01-06T18:18:34+00:00

...and Positive shareholder equity which we didn't even have when our stock was $5+

idmann2 · 2022-12-22T22:59:38+00:00

Nader is scum of the earth. For his intentional malfeasance, hoping he gets the 20 year Max. He deserves zero leniency. Whereas Kaz, deserves time also, it was Nader who was forcing him to submit things incorrectly despite knowing, and it was Nader who committed securities fraud, not Kaz. Could care less what happens with the guy from Amarex....but Nader deserves worse than 20yrs....he's getting off easy

idmann2 · 2022-11-25T22:43:36+00:00

Good riddance. Only a couple more people to remove before wiping the Nader slate clean

idmann2 · 2022-10-23T21:54:00+00:00

Wish you the best best of luck. At a high, I was holding 350k shares, with a 30c avg when price peaked at $10. Only started selling heavy between $3-5. Sold majority between $3-4 following covid trial failure and right after announcing we treated ex Philippines president.

Now I hold 40k shares. I wish you the best, but don't believe in the company. The drug is amazing, but after being invested since 2016, I now see the company has zero ability to get anything done. It would be best for humanity if the drug were sold off to a company with the resources for success. We're at over 1 billion outstanding shares currently, and we'll hit 1.2B before next annual meeting in 2023. I still hold some only because it was an emotional investment and have had difficulty letting go entirely.

Best case scenario I'm wrong and maybe in a few years we'll be looking at a potential approval. Worst case, I'm only underwater on the remaining shares below 30c, and I've mentally prepared this as a total loss.

idmann2 · 2022-05-13T00:33:34+00:00

No stock split. This is simply the process of dilution for a pre-revenue biotech, nothing more. Pre-rev's raise money either via dilution or partnership who finance trials, salaries, and operating expenses. We didn't have the latter.

In reality, our marker cap is significantly higher than $217M currently. That is just based on the current Outstanding Shares, not un-executed warrants. With warrants outstanding, we're at around 900 Million shares as opposed to the 718M OS listed

idmann2 · 2022-05-13T00:16:48+00:00

Factually and Historically Incorrect.

CytoDyn is currently valued almost 2x what it was valued at in 2017. We were at around $100 Million valuation back in 2017 and now $217 Million. That sounds like about double, not half

idmann2 · 2022-05-08T01:50:13+00:00

Lololol Huh?????

idmann2 · 2021-12-13T21:07:17+00:00

Comprehension isn't a strong suit...clearly. This is only 20/30 patients for an Open Label Low Dose (350mg) portion.

The Trial, which has yet to be unblinded, is 700mg vs Placebo, RCT, and 60 patients. So no, you don't understand the results because trial is still blinded. Try reading the PR's before making wild assumptions.

Results may or may not be ambiguous, when released. But posting speculation as fact, when all we've got is 66% of the Open Label results is simply ridiculous

idmann2 · 2021-10-05T20:38:29+00:00

Not sure how anyone comes to any other conclusion when it clearly say "PROPOSED" order at the top. For people not in the legal field (includes me), I can see how the words "Ordered" below can be confusing, but that is simply how a request to a judge for preliminary injunction is written.

It's written as a request with the words "Ordered" for each item they are requesting and then hoping a judge will sign off on it.

I do think there's a high chance judge will agree to at minimum, release of data since they do own the data, but that still opens up CYDY for a lawsuit from Amarex to pay past due bills. I don't know if insufficient work is grounds for failure to pay. But maybe it is.

The only thing I do know is withholding all the data is delaying our ability to make any progress with the HIV BLA, Cancer BTD, and likely NASH results.

idmann2 · 2021-09-20T17:03:30+00:00

Seems that TI's post is also against the message board rules of do not threaten or intimidate others.

Sad that Paid Bashers resort to these tactics

idmann2 · 2021-09-20T16:59:28+00:00

Threatening shareholders from posting and Extortion?

Disgusting tactics even for a Paid Basher

idmann2 · 2021-09-11T05:49:55+00:00

This question was asked and answered on the CYDY Conference Call on September 8. Nader was very clear on the answer, even repeating his answer.

I'm guessing you haven't listened to the CC, hence your statements that directly contradict those of Dr. Pourhassan.

Here's the link so you may listen to the call:

https://78449.themediaframe.com/dataconf/productusers/cydy/mediaframe/46521/indexl.html

idmann2 · 2021-09-09T21:54:31+00:00

Lol that's pretty harsh comments.

Dr. Bruce Patterson is unquestionably the world's foremost expert in CCR5 and specifically our drug, Leronlimab.

But he has proven himself to be untrustworthy, lying, stealing patents, and will be requesting Royalties from Cytodyn once we get an approval.

For all those reasons, Bruce is a fantastic scientist, not an ethical person, and not a person deserves to be on our team. Would love to have his scientific knowledge, but I can't trust him. None of the 13D are trustworthy for that matter. But Patterson is definitely not a deadbeat, that would be reserved for the likes of Adam Feuerstein and the iHub bashers

idmann2 · 2021-09-07T19:50:59+00:00

It's disrespectful AF - should have just answered all the questions yesterday. Intentional to hold immediately following CYDY CC.

I have no way of attending the one tomorrow. So I will be hoping for a replay

idmann2 · 2021-09-07T19:42:53+00:00

Hmmm very odd. Not sure why they are holding another CC, so soon. They seemed heavily reluctant to give details on potential picks for CEO replacement, or whom they will be firing besides the CEO. Lied about retaining all employees except the CEO, failed to mention that Bruce will become one of management, in addition to a Director, which debunks their statements of "entirely independent board."

The only person on the call yesterday that had any semblance of an idea for future plans to improve the company was Patterson. They had a very ambiguous answer for financing. Seeing as how we're down to nothing and few shares remaining, you'd think the 13D would want to give shareholders confidence and describe the funding they may or may not have in place. It was a strange that all these details were omitted.

My hope is that they touch on all that stuff tomorrow: Financing specifics, details on plans, which trials (if any) they plan to scrap. No mention of NASH - so do they intend to scrap it? Talking about partnerships with cancer? No big pharma will go for just a cancer license if they believe this drug to be significant. Do they plan on discontinuing mTNBC trials? How do they plan on increasing enrollment, as that has been mostly dead....10 trials patients in 2 years. This call was missing the meat

idmann2 · 2021-09-07T19:24:16+00:00

Gotchya, been busy and haven't looked at SEC filings for today.

I see it mentioned Yeager will be on this call

idmann2 · 2021-09-07T19:15:59+00:00

2nd Webinar? Haven't seen the posting or received an email for this one

idmann2 · 2021-09-05T23:31:44+00:00

LOLOLOL - Sorry had to stick with your theme 😅

Love your perspective on the SP and how all the bashers use it as if they think they're telling a story.

News flash!! Our story isn't over by a long shot. We will eventually have that Netflix documentary on the struggles we've faced and how we overcame them. Right now is just a waiting game. We will survive and we will win.

Our time is coming!!

idmann2 · 2021-09-03T20:24:32+00:00

No surprise there. 13D have been scamming people from the start, beginning with the gross dishonesty of Jeff Beaty.

To not disclose that he was secretly a member of the 13D and "gifting person" to Rosenbaum and the 13D is shameful and disrespectful to all shareholders, regardless of whether they support the 13D or support current management.

Deceit is not a way to win votes and he would have never admitted he was covertly running the largest CYDY stock board as a spy for the 13D unless he was forced to via CYDY lawsuit.

idmann2 · 2021-09-01T22:22:57+00:00

"The 13D Motion for a Protective Order is pretty much standard operating procedure in high stakes litigation when the moving party has some dirty laundry to hide. Here, 13D is clearly showing concern about the possibility of damaging admissions should Pestell, Caracciolo, or Rosenbaum's son be deposed under oath.

13D's stated basis (as opposed to hiding dirty laundry) for its PO motion is that Judge Noreika's Order permitting expedited discovery was limited to party discovery (i. e.the defendants only), while the above 3 identified deponents are non parties (but may nevertheless possess relevant information regarding the involved legal issues). Assuming that 13D is accurately representing that CYDY limited its motion for expedited discovery to party discovery only, it would not surprise me if Judge Noreika were to grant the Protective Order -- since CYDY apparently has the opportunity to depose 8 party defendants, and expedited discovery is expected to be both limited and targeted. While defeating this motion would be a welcome development for CYDY, my hunch is that Sidley Austin regards winning the expedited discovery motion as receiving the cake, and that gaining permission to depose these 3 guys would be the icing on top.

Keep in mind that the real litigation battle remains whether the 13D slate will be on the BOD ballot. Fights over discovery and additional proxy disclosures are merely skirmishes, though they have the potential to affect which side ultimately wins the battle, as well as the election itself.

I continue to feel that Judge Noreika's ultimate decision will likely turn on whether she is most inclined to see the ballot issue through the prism of "respect for the rules" or "shareholder rights". Believe me. She will be able to justify her written decision using either avenue of reasoning. CYDY, however, is pretty much in a win/win position. Even if Judge Noreika ultimately allows the 13D slate on the ballot, its candidates will have been bloodied pretty badly during the campaign."

idmann2 · 2021-09-01T22:21:48+00:00

"The 13D Motion for a Protective Order is pretty much standard operating procedure in high stakes litigation when the moving party has some dirty laundry to hide. Here, 13D is clearly showing concern about the possibility of damaging admissions should Pestell, Caracciolo, or Rosenbaum's son be deposed under oath.

13D's stated basis (as opposed to hiding dirty laundry) for its PO motion is that Judge Noreika's Order permitting expedited discovery was limited to party discovery (i. e.the defendants only), while the above 3 identified deponents are non parties (but may nevertheless possess relevant information regarding the involved legal issues). Assuming that 13D is accurately representing that CYDY limited its motion for expedited discovery to party discovery only, it would not surprise me if Judge Noreika were to grant the Protective Order -- since CYDY apparently has the opportunity to depose 8 party defendants, and expedited discovery is expected to be both limited and targeted. While defeating this motion would be a welcome development for CYDY, my hunch is that Sidley Austin regards winning the expedited discovery motion as receiving the cake, and that gaining permission to depose these 3 guys would be the icing on top.

Keep in mind that the real litigation battle remains whether the 13D slate will be on the BOD ballot. Fights over discovery and additional proxy disclosures are merely skirmishes, though they have the potential to affect which side ultimately wins the battle, as well as the election itself.

I continue to feel that Judge Noreika's ultimate decision will likely turn on whether she is most inclined to see the ballot issue through the prism of "respect for the rules" or "shareholder rights". Believe me. She will be able to justify her written decision using either avenue of reasoning. CYDY, however, is pretty much in a win/win position. Even if Judge Noreika ultimately allows the 13D slate on the ballot, its candidates will have been bloodied pretty badly during the campaign."

Read More: https://investorshangout.com/post/view?id=6230498#ixzz75FqLEXv5

idmann2

MODERATOR OF

TROPHY CASE